The exchange traded funds for gold (NYSE: GLD), SPDR Gold Shares, and silver, iShares Silver Trust (NYSE: SLV), rose last September when Federal Reserve Chairman Ben Bernanke introduced Quantitative Easing III. But that rise did not last, as took place with the periods after Quantitative Easing I and Quantitative Easing II. But investors should expect the GLD and the SLV along with precious metal stocks such as Barrick Gold (NYSE: ABX) and Wishbone Gold PLC (PINK: WISHY) to reward long term shareholders.
For 2013, SPDR Gold shares is off more than 20% for 2013. iShares Silver Trust is down by nearly 30% for the same period. Since the beginning of the year, Barrick Gold has fallen by more than 40%.
All are up in trading today, due to Ben Bernanke's statement that Quantitative Easing III will continue in its present form.
10 Best Beverage Stocks To Own Right Now: Constant Contact Inc.(CTCT)
Constant Contact, Inc. provides on-demand email marketing, social media marketing, event marketing, and online survey products primarily in the United States. It offers email marketing products, which allow customers to create, send, and track professional and affordable permission-based email marketing campaigns; and social media marketing products that allow customers to manage and optimize their presence across multiple social media networks. The company also provides event marketing products, which enable its customers to promote and manage events, communicate with invitees and registrants, capture and track registrations, and collect online payments; and online survey products that enable its customers to create and send surveys, and analyze the responses. In addition, it offers customer support services to customers and trailers through phone, chat, email, and social media. Further, the company provides ancillary services, such as custom services to customers who lik e its email campaigns, event promotions, or surveys prepared for them; and online training programs to educate participants on email marketing and social media marketing best practices, as well as a workshop programs. It markets its products directly for small organizations, including retailers, restaurants, law and accounting firms, consultants, non-profits, religious organizations, and alumni associations. The company was formerly known as Roving Software Incorporated and changed its name to Constant Contact, Inc. in 2006. Constant Contact, Inc. was founded in 1995 and is headquartered in Waltham, Massachusetts.
Advisors' Opinion:- [By Jake L'Ecuyer]
Equities Trading UP
Constant Contact (NASDAQ: CTCT) was up on Friday's session, gaining 11.06 percent to $29.12 after the company's earnings report and guidance impressed the street. - [By Jake L'Ecuyer]
Technology sector was the leading decliner in the US market today. Top losers in the sector included Constant Contact (NASDAQ: CTCT), off 8.1 percent, and Ku6 Media Co (NASDAQ: KUTV), down 9.1 percent.
- [By Evan Niu, CFA]
What: Shares of Constant Contact (NASDAQ: CTCT ) have popped today by upwards of 19% after the company reported first-quarter earnings.
Top 10 Long Term Companies To Own In Right Now: VIVUS Inc (VVUS)
VIVUS, Inc., incorporated on May 16, 1996, is a biopharmaceutical company. It commercializes and develops therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. The Company's drug, Qsymia (phentermine and topiramate extended-release) was approved by the the United States Food and Drug Administration (FDA) for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 or greater (obese), or 27 or greater (overweight) in the presence of at least one weight-related comorbidity, such as hypertension, type 2 diabetes mellitus or high cholesterol (dyslipidemia). Qsymia incorporates low doses of active ingredients from two previously approved drugs, phentermine and topiramate. It has completed Phase 2 clinical studies for Qsymia for the treatment of sleeps apnea and Qsymia for the treatment of type 2 diabetes. Its drug also includes STENDRA, or avanafil.
Qsymia for the treatment of obesity was approved as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial BMI of 30 or greater (obese), or 27 or greater (overweight) in the presence of at least one weight-related comorbidity, such as hypertension, type 2 diabetes mellitus or high cholesterol (dyslipidemia). Qsymia incorporates low doses of active ingredients from two previously approved drugs, phentermine and topiramate.
The Company initially launched Qsymia for distribution to eligible patients through the home delivery networks of two certified pharmacies, CVS Pharmacy and Walgreens. Since then, it has expanded the distribution of Qsymia to include the home delivery networks of Express Scripts, Wal-Mart Pharmacy and, for its members only, Kaiser Permanente. Clinical studies of topiramate, a component of Qsymia, in type 2 diabetics resulted in a clinically reduction of hemoglobin A1c (HbA1c). The! Company's drug, STENDRA (avanafil), is an oral PDE5 inhibitor the Company has licensed from Mitsubishi Tanabe Pharma Corporation (MTPC).
Advisors' Opinion:- [By John Udovich]
Orexigen Therapeutics, Inc (NASDAQ: OREX), like Arena Pharmaceuticals, Inc (NASDAQ: ARNA), EnteroMedics Inc (NASDAQ: ETRM) and VIVUS, Inc (NASDAQ: VVUS), is a speculative small cap obesity drug stock that has the potential for coming up with the next big thing in the treatment of obesity that is increasingly a global problems. I should mention that we have recently added Orexigen Therapeutics to our SmallCap Network Elite Opportunity (SCN EO) portfolio as an extremely speculative biotech bet because its�lead obesity drug candidate has the potential to be�approved by September 11th of this year.
Top 10 Long Term Companies To Own In Right Now: United Stationers Inc.(USTR)
United Stationers Inc., through its subsidiary, United Stationers Supply Co., engages in the wholesale distribution of business products in North America. The company distributes technology products, which include computer supply and peripheral products, including imaging supplies, data storage, digital cameras, computer accessories, and computer hardware items. It also offers traditional office products consisting of brand-name and private label office supply products, such as filing and record storage products, business machines, presentation products, writing instruments, paper products, shipping and mailing supplies, calendars, and general office accessories; and office furniture products comprising desks, filing and storage solutions, and seating and systems furniture. In addition, the company distributes janitorial and breakroom supply items, including cleaners and cleaning accessories; foodservice consumables, such as disposable cups, plates, and utensils; safety an d security items; and paper and packaging supplies. Further, it provides industrial supply items, such as hand and power tools; safety and security supplies; janitorial equipment and supplies; industrial maintenance, repair, and operations (MRO) items; and oil field and welding supplies. Additionally, the company offers freight, advertising, and software services, as well as sells software products. It serves independent office products dealers; contract stationers; office products superstores; computer products resellers; office furniture dealers; mass merchandisers; mail order companies; sanitary supply, paper, and foodservice distributors; drug and grocery store chains; healthcare distributors; e-commerce merchants; oil field, welding supply, and industrial/MRO distributors; and other independent distributors through its network of 65 distribution centers and 37 re-distribution points. United Stationers Inc. was founded in 1922 and is headquartered in Deerfield, Illinois.
Advisors' Opinion:- [By Rich Duprey]
Business supplies distributor�United Stationers (NASDAQ: USTR ) announced on Friday its third-quarter dividend of $0.14 per share, the same rate it's paid for the past three quarters after raising the payout 8% from $0.13 per share.
- [By Monica Gerson]
United Stationers (NASDAQ: USTR) is projected to post its Q3 earnings at $0.99 per share on revenue of $1.33 billion.
Wynn Resorts (NASDAQ: WYNN) is estimated to post its Q3 earnings at $1.65 per share on revenue of $1.36 billion.
Top 10 Long Term Companies To Own In Right Now: Farmer Brothers Company(FARM)
Farmer Bros. Co. engages in the manufacture, wholesale, and distribution of coffee, tea, and culinary products. Its product line includes roasted coffee; liquid coffee; and coffee related products, such as coffee filters, sugar and creamers, assorted teas, cappuccino, cocoa, spices, gelatins and puddings, soup, gravy and sauce mixes, pancake and biscuit mixes, and jellies and preserves. The company distributes its products through direct and brokered sales to institutional foodservice establishments, including restaurants, hotels, casinos, hospitals, and foodservice providers, as well as retailers, such as convenience stores, coffee houses, general merchandisers, private label retailers, and grocery stores in the United States. Farmer Bros. Co. was founded in 1912 and is headquartered in Torrance, California.
Advisors' Opinion:- [By Eric Volkman]
Farmer Brothers (NASDAQ: FARM ) has a new top financial executive. The company has appointed Mark Nelson to its CFO and treasurer positions, effective April 15. He will initially be assisted by, then replace, interim Treasurer and CFO Jeffrey Wahba.�
- [By Laura Brodbeck]
Monday
Earnings Releases Expected: Diamond Foods, Inc. (NASDAQ: DMND), Farmer Brothers Company (NASDAQ: FARM) Economic Releases Expected: US Chicago PMITuesday
Top 10 Long Term Companies To Own In Right Now: Asante Gold Corp (ASE)
Asante Gold Corporation is a mineral exploration company involved in the acquisition and assessment of mineral properties in the Republic of Ghana. The Company is a gold royalty, exploration and development company. The Company is focused in Ghana, West Africa where it is exploring the Fahiakoba concession, a 22.07 square kilometers prospecting license located on strike with and between Perseus Mining's 4.32 million ounce Edikan Mine and AngloGold Ashanti's 60 million ounce Obuasi mine. It has a 100% interest in the Fahiakoba concession. ASG Mining Ltd. is the Company�� 100% owned Ghana subsidiary. Advisors' Opinion:- [By Namitha Jagadeesh]
Greece�� ASE Index (ASE) retreated 4 percent today, pulled down by shares of lenders. National Bank of Greece SA tumbled 27 percent to 1.15 euros after announcing details of a share sale. Piraeus Bank SA slid 21 percent to 36 euro cents.
Top 10 Long Term Companies To Own In Right Now: AVEO Pharmaceuticals Inc.(AVEO)
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of cancer therapeutics. The company?s lead product candidate, Tivozanib (AV-951), is a novel, highly potent and selective oral inhibitor of the vascular endothelial growth factor, or VEGF, receptors 1, 2, and 3. It is also leading the clinical development of AV-299, which includes conducting multiple Phase I clinical trials and preparing for the conduct of multiple Phase II clinical trials. The company?s product candidate in preclinical development is AV-203, a potent ErbB3 antibody that has demonstrated efficacy in vivo. It has strategic partnerships with OSI Pharmaceuticals, Inc., Merck, and Biogen Idec, Inc. AVEO Pharmaceuticals was formerly known as GenPath Pharmaceuticals, Inc. and changed its name to AVEO Pharmaceuticals, Inc. in March 2005. The company was founded in 2001 and is based in Cambridge, Massachusetts.
Advisors' Opinion:- [By Sean Williams]
The ugly
Finally, in a case of "kick 'em while they're down," AVEO Pharmaceuticals (NASDAQ: AVEO ) was sucker-punched by partner Astellas Pharma on Friday. Astellas informed AVEO of its intent not to file for regulatory approval in Europe for Tivozanib and commented that it had no intentions of funding any additional studies of the drug with regard to renal cell carcinoma, or RCC. That's bad news for AVEO, which got the thumbs-down from the FDA's panel three weeks ago and recommended AVEO run another trial. I wouldn't completely discount the possibility that Tivozanib would show a statistical benefit in treating RCC, but the mounting costs of running another trial are certain to be burdensome on AVEO. - [By Eric Volkman]
AVEO Oncology (NASDAQ: AVEO ) will have to plow forward with far less manpower. It announced it will reduce its headcount by around 140 people, or roughly 62% of its current workforce, across the company. The cuts are part of a strategic restructuring initiative aimed at improving the firm's viability in the immediate future.�
- [By Sean Williams]
Finally, clinical-stage cancer drug developer AVEO Pharmaceuticals (NASDAQ: AVEO ) certainly shook things up this week by announcing it will be laying off 140 employees or 62% of its staff to cut its expenses and extend its existing cash balance for another two years. Furthermore, AVEO outlined its plan to focus on developing its lead cancer drug, Tivozanib, for breast and colorectal cancer, but not for renal cell carcinoma. Management noted that it doesn't believe the FDA would approve Tivozanib for RCC without the need for additional testing that it isn't prepared to do right now, with Astellas Pharma having backed out of their development partnership.�
- [By Sean Williams]
Despite this seemingly endless parade of advanced RCC treatments, there have also been some notable failures -- perhaps none more fresh than AVEO Pharmaceuticals' (NASDAQ: AVEO ) implosion this past week. AVEO's lead drug, Tivozanib, provided a statistically significant median PFS advantage over Nexavar in late-stage trials, but it failed to produce a median overall survival gain compared to Nexavar. That confusing stat prompted the FDA's panel to vote 13-1 against recommending Tivozanib for approval. While not dead, it's going to take at least another trial it seems to justify Tivozanib's benefits.
Top 10 Long Term Companies To Own In Right Now: Pepsico Inc.(PEP)
PepsiCo, Inc. engages in the manufacture, marketing, and sale of foods, snacks, and carbonated and non-carbonated beverages worldwide. The company operates in four divisions: PepsiCo Americas Foods (PAF); PepsiCo Americas Beverages (PAB); PepsiCo Europe; and PepsiCo Asia, Middle East, and Africa (AMEA). The PAF division offers Lay?s and Ruffles potato chips, Doritos and Tostitos tortilla chips and dips, Cheetos cheese flavored snacks, Fritos corn chips, Quaker Chewy granola bars, and SunChips multigrain snacks in North America; Quaker oatmeal, Aunt Jemima mixes and syrups, Cap?n Crunch cereal, Quaker grits, and Life cereal, as well as Rice-A-Roni, Pasta Roni, and Near East side dishes in North America; and various snack foods under Doritos, Marias Gamesa, Cheetos, Ruffles, Emperador, Saladitas, Sabritas, and Lay?s brands in Latin America. The PAB division provides carbonated soft drinks, beverage concentrates, fountain syrups, and finished goods under Pepsi, Mountain Dew, Gatorade, 7UP, Tropicana Pure Premium, Electropura, Sierra Mist, Epura, and Mirinda brands; ready-to-drink tea, coffee, and water products through joint ventures with Unilever and Starbucks; and sells concentrate to authorized bottlers, and branded finished goods directly to independent distributors and retailers. This division also manufactures third-party brands, such as Dr Pepper, Crush, Rock Star, and Muscle Milk. The PepsiCo Europe division offers Frito Lay Snacks, Pepsi-Cola beverages, Gatorade sports drinks, Tropicana juices, and Quaker foods in Europe. The AMEA division provides snack food under the Lay?s, Kurkure, Chipsy, Doritos, Smith?s, Cheetos, Red Rock Deli, and Ruffles brands; Quaker-brand cereals and snacks; and beverage concentrates, fountain syrups, and finished goods under the Pepsi, Mirinda, 7UP, and Mountain Dew brands. PepsiCo, Inc. was founded in 1898 and is headquartered in Purchase, New York.
Advisors' Opinion:- [By Alyce Lomax]
There are different variations of the anti-Monsanto social meme�floating around, claiming that companies and brands like Procter & Gamble (NYSE: PG ) , PepsiCo (NYSE: PEP ) , Coca-Cola,�and other household names are owned by Monsanto.
No comments:
Post a Comment